Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
1,104.101,103.921,108.751,097.16
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
604.16604.16610.19604.12
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
1,197.811,200.581,213.071,192.02
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
1,740.411,739.551,750.271,730.60
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
634.44633.13639.87633.01
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
840.90839.53841.73831.10
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
215.13215.13215.85213.24
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
3,228.713,225.623,235.433,198.95
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
935.87938.37942.00935.65
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
1,457.121,452.741,466.881,449.18
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
2,399.842,389.712,394.612,371.22
NWBO:OTCMKTS
Northwest Biotherapeutics Inc
$0.19
-3.94%
(-0.0080) 1D
$0.19
0.00% (0.00)
After hours
Closed: Apr 27, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NWBO...
Open
$0.22
High
$0.25
Low
$0.19
Mkt. cap
317.40M
Avg. vol.
2.32M
Volume
10.36M
52-wk high
$0.38
52-wk low
$0.19
EPS
-$0.04
Beta
-0.77
Shares outstanding
1.61B
No. of employees
105
News stories
From sources across the web
Profile
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
About Northwest Biotherapeutics Inc
CEO-
Employees105
FoundedJan 1, 1998
Headquarters-
SectorBiotechnology
Websitenwbio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
375.00K
131.00K
200.00K
672.00K
Cost of goods sold
8.35M
7.43M
7.45M
5.55M
Cost of revenue
8.35M
7.43M
7.45M
5.55M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.34M
7.48M
7.07M
8.62M
Operating expense
9.34M
7.48M
7.07M
8.62M
Total operating expenses
17.69M
14.91M
14.52M
14.18M
Operating income
-17.31M
-14.78M
-14.32M
-13.50M
Other non operating income
1.26M
484.00K
-3.45M
1.14M
EBT including unusual items
-19.34M
-15.38M
-26.83M
851.00K
EBT excluding unusual items
-15.76M
-12.48M
-21.20M
-14.82M
Income tax expense
-
-
-
-537.00K
Effective tax rate
-
-
-
-63.10%
Other operating expenses
-
-
-
-
Net income
-19.34M
-15.38M
-26.83M
1.39M
Net profit margin
-5,158.13%
-11,738.93%
-13,414.50%
206.55%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.60M
-1.83M
-2.62M
-2.65M
Net interest expenses
-1.60M
-1.83M
-2.62M
-2.65M
Depreciation and amortization charges
-
-
-
-
EBITDA
-16.88M
-14.33M
-13.87M
-12.78M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more